BriaCell Therapeutics Corp. (BCTX) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

BriaCell Therapeutics Corp.

BCTX

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

31M

Biotechnology

Next Earning date - 30 Oct 2024

31M

Biotechnology

Next Earning date - 30 Oct 2024

0.87USD

-0.02 ( -2.58%)

Relative Strenght

4

Volume Buzz

-89%

Earning Acce

No

Dist 52w H.

85%

Quote Panel

Updated October 28, 2024

1W -0.60 % 1M -30.08 % 3M 17.64 % 1Y -78.33 %

Key Metrics

Market Cap
31.07M
Shares Outstanding
35.84M
Share in Float
31.59M
Dividende
0

Earning Date
30 Oct 2024
Price Target
0.867
Average Volume
4.85M
Beta
1.834

Range
0.46-5.97
Industry
Biotechnology
Website
https://www.briacell.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

-2.33x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.4

EPS

How BCTX compares to sector?

P/E Ratio

Relative Strength

BCTX

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

0

$0.79

-819%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q2.22

N/A

-0.32
vs -0.93

Q3.22

N/A

-1.01
vs 0.05

Q4.22

N/A

-0.07
vs -0.15

Q1.23

N/A

-0.77
vs -0.24

Q2.23

N/A

-0.32
vs -0.32

Q3.23

N/A

-0.15
vs -1.01

Q4.23

N/A

-0.50
vs -0.07

Q1.24

N/A

-0.71
vs -0.77

Q2.24

+134%

0.11
vs -0.32

Q3.24

N/A

-0.71
vs -0.15

Sales Growth

YoY

Current

Estimates

Q1.22

NA

NA vs NA

Q2.22

NA

NA vs NA

Q3.22

NA

NA vs NA

Q4.22

NA

NA vs NA

Q1.23

NA

NA vs NA

Q2.23

NA

NA vs NA

Q3.23

NA

NA vs NA

Q4.23

NA

NA vs NA

Q1.24

NA

NA vs NA

Q2.24

NA

NA vs NA

Return on Equity

QoQ

Q3.22

-170%

-1.70
vs -0.20

Q4.22

+31%

0.31
vs -1.70

Q1.23

+928%

9.28
vs 0.31

Q2.23

+74%

0.74
vs 9.28

Q3.23

+64%

0.64
vs 0.74

Q4.23

+221%

2.21
vs 0.64

Q1.24

+142%

1.42
vs 2.21

Q2.24

-29%

-0.29
vs 1.42

Institutionnal Ownership

QoQ

Q2.22

28

28
vs 24

17%

Q3.22

28

28
vs 28

NA

Q4.22

24

24
vs 28

-14%

Q1.23

24

24
vs 24

NA

Q2.23

25

25
vs 24

4%

Q3.23

2

2
vs 25

-92%

Q4.23

2

2
vs 2

NA

Q1.24

1

1
vs 2

-50%

Earnings Growth

Latest News

BCTX

globenewswire.com

7 hours ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

BCTX

globenewswire.com

7 hours ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

BCTX

globenewswire.com

7 hours ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

BCTX

seekingalpha.com

14 hours ago

BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns

BCTX

globenewswire.com

14 hours ago

BriaCell Therapeutics Announces $5 Million Offering

BCTX

globenewswire.com

16 hours ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

New Feature Coming Soon, Stay Tuned!

Shape

Shape